Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
4 hedge funds and large institutions have $2.4M invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
13.51% more ownership
Funds ownership: 0% → 13.51% (+14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$765K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$640K |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$574K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$230K |
Top Sellers
PILL Hedge Fund Activity: Q2 2021 in Review
4 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q2 2021, worth a combined $2.4M.
Buyers outnumbered sellers: 4 funds opened new PILL positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Old Mission Capital, opening a new position worth an estimated $765K.
- 4 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $2.4M of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q2 2021.
- 4 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q2 2021 and 0 closed out, a net change of +4 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q2 2021 was Old Mission Capital, an estimated $765K added.
Based on aggregated 13F filings for Q2 2021.